Diseases, Conditions, Syndromes

Swiss giant Novartis halts COVID-19 hydroxychloroquine study

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.

Diseases, Conditions, Syndromes

'Promising evidence' that osteopathy may relieve musculoskeletal pain

There's "promising evidence" that osteopathy, the physical manipulation of the body's tissues and bones, may relieve the pain associated with musculoskeletal conditions, finds a review of the available clinical evidence, ...

Medications

New drug molecule for treatment of atrial fibrillation

Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceutical drug for the treatment of the most common heart rhythm disturbance—atrial fibrillation (AF). The ...

page 8 from 40